SG11201807676UA - Method for protein purification - Google Patents
Method for protein purificationInfo
- Publication number
- SG11201807676UA SG11201807676UA SG11201807676UA SG11201807676UA SG11201807676UA SG 11201807676U A SG11201807676U A SG 11201807676UA SG 11201807676U A SG11201807676U A SG 11201807676UA SG 11201807676U A SG11201807676U A SG 11201807676UA SG 11201807676U A SG11201807676U A SG 11201807676UA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- ucb
- co7k
- ipd
- pct
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
- B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
- B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/265—Adsorption chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/20—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising free carbon; comprising carbon obtained by carbonising processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/282—Porous sorbents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J47/00—Ion-exchange processes in general; Apparatus therefor
- B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201605562 | 2016-04-01 | ||
PCT/EP2017/057685 WO2017167960A1 (en) | 2016-04-01 | 2017-03-31 | Method for protein purification |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201807676UA true SG11201807676UA (en) | 2018-10-30 |
Family
ID=58461345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201807676UA SG11201807676UA (en) | 2016-04-01 | 2017-03-31 | Method for protein purification |
Country Status (18)
Country | Link |
---|---|
US (1) | US11014962B2 (zh) |
EP (1) | EP3436173A1 (zh) |
JP (2) | JP7012023B2 (zh) |
KR (1) | KR102413808B1 (zh) |
CN (1) | CN108883345B (zh) |
AU (1) | AU2017242900B2 (zh) |
BR (1) | BR112018068803A2 (zh) |
CA (1) | CA3016847C (zh) |
CL (1) | CL2018002689A1 (zh) |
CO (1) | CO2018010286A2 (zh) |
EA (1) | EA201892231A1 (zh) |
HK (1) | HK1257713A1 (zh) |
IL (1) | IL261560B (zh) |
MX (1) | MX2018011435A (zh) |
MY (1) | MY197993A (zh) |
RU (1) | RU2737539C2 (zh) |
SG (1) | SG11201807676UA (zh) |
WO (1) | WO2017167960A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023136820A1 (en) * | 2022-01-13 | 2023-07-20 | Bayer Healthcare Llc | Improved antibody manufacture |
WO2024110444A1 (en) | 2022-11-21 | 2024-05-30 | Chreto Aps | Method for purification of a target product using affinity purification technology |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5659795A (en) * | 1979-10-22 | 1981-05-23 | Kanegafuchi Chem Ind Co Ltd | Purification of nicotinic acid amide adenine dinucleotide |
JP5808249B2 (ja) * | 2008-10-20 | 2015-11-10 | アッヴィ・インコーポレイテッド | プロテインaアフィニティークロマトグラフィーを用いる抗体の単離および精製 |
US9096648B2 (en) * | 2011-08-19 | 2015-08-04 | Emd Millipore Corporation | Methods of reducing level of one or more impurities in a sample during protein purification |
CN104105703A (zh) * | 2012-03-26 | 2014-10-15 | Emd密理博公司 | 带电的氟碳化合物组合物在纯化生物分子的方法中的用途 |
EP2682168A1 (en) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Purification of biological molecules |
US9650411B2 (en) * | 2012-08-07 | 2017-05-16 | Kyowa Hakko Kirin Co., Ltd. | Method of purifying protein |
AU2014234962C1 (en) * | 2013-03-21 | 2019-01-17 | Evonik Operations Gmbh | Purification of triple helical proteins |
WO2015005961A1 (en) | 2013-07-12 | 2015-01-15 | Emd Millipore Corporation | A method of determining virus removal from a sample containing a target protein using activated carbon |
US10519194B2 (en) * | 2013-07-12 | 2019-12-31 | Merck Patent Gmbh | Removal of fragments from a sample containing a target protein using activated carbon |
CN104546715B (zh) | 2014-12-22 | 2018-01-16 | 蓝佳堂生物医药(福建)有限公司 | 一种用于上呼吸道感染的复合抗体口腔喷剂及其制备方法 |
-
2017
- 2017-03-31 AU AU2017242900A patent/AU2017242900B2/en active Active
- 2017-03-31 WO PCT/EP2017/057685 patent/WO2017167960A1/en active Application Filing
- 2017-03-31 KR KR1020187031874A patent/KR102413808B1/ko active IP Right Grant
- 2017-03-31 EA EA201892231A patent/EA201892231A1/ru unknown
- 2017-03-31 JP JP2018551087A patent/JP7012023B2/ja active Active
- 2017-03-31 BR BR112018068803A patent/BR112018068803A2/pt unknown
- 2017-03-31 MY MYPI2018703312A patent/MY197993A/en unknown
- 2017-03-31 CN CN201780020300.8A patent/CN108883345B/zh active Active
- 2017-03-31 SG SG11201807676UA patent/SG11201807676UA/en unknown
- 2017-03-31 MX MX2018011435A patent/MX2018011435A/es unknown
- 2017-03-31 US US16/089,443 patent/US11014962B2/en active Active
- 2017-03-31 CA CA3016847A patent/CA3016847C/en active Active
- 2017-03-31 EP EP17714759.2A patent/EP3436173A1/en active Pending
- 2017-03-31 RU RU2018138445A patent/RU2737539C2/ru active
-
2018
- 2018-09-03 IL IL261560A patent/IL261560B/en active IP Right Grant
- 2018-09-21 CL CL2018002689A patent/CL2018002689A1/es unknown
- 2018-09-26 CO CONC2018/0010286A patent/CO2018010286A2/es unknown
-
2019
- 2019-01-03 HK HK19100083.7A patent/HK1257713A1/zh unknown
-
2021
- 2021-11-24 JP JP2021189889A patent/JP2022036993A/ja not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2019512255A (ja) | 2019-05-16 |
CA3016847A1 (en) | 2017-10-05 |
EP3436173A1 (en) | 2019-02-06 |
MX2018011435A (es) | 2019-01-10 |
WO2017167960A1 (en) | 2017-10-05 |
CA3016847C (en) | 2023-12-19 |
RU2018138445A (ru) | 2020-05-12 |
MY197993A (en) | 2023-07-25 |
HK1257713A1 (zh) | 2019-10-25 |
KR102413808B1 (ko) | 2022-06-29 |
CO2018010286A2 (es) | 2018-10-31 |
IL261560B (en) | 2021-06-30 |
US11014962B2 (en) | 2021-05-25 |
IL261560A (en) | 2018-10-31 |
CN108883345B (zh) | 2022-09-13 |
JP2022036993A (ja) | 2022-03-08 |
CN108883345A (zh) | 2018-11-23 |
CL2018002689A1 (es) | 2018-11-23 |
JP7012023B2 (ja) | 2022-01-27 |
RU2018138445A3 (zh) | 2020-07-07 |
US20190153028A1 (en) | 2019-05-23 |
BR112018068803A2 (pt) | 2019-01-22 |
AU2017242900A1 (en) | 2018-10-04 |
KR20180131599A (ko) | 2018-12-10 |
RU2737539C2 (ru) | 2020-12-01 |
AU2017242900B2 (en) | 2022-07-28 |
EA201892231A1 (ru) | 2019-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201909955XA (en) | Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies | |
SG11201908391XA (en) | Methods for modulating an immune response | |
SG11201808724SA (en) | Anti-tim-3 antibodies and compositions | |
SG11201808242UA (en) | Methods for inhibiting angiogenesis in a subject in need thereof | |
SG11201811003PA (en) | Anti-pd-l1 antibodies and uses thereof | |
SG11201807489PA (en) | Cells expressing multiple chimeric antigen receptor (car) molecules and uses therefore | |
SG11201910134SA (en) | Stable formulations of anti-ctla4 antibodies alone and in combination with programmed death receptor 1 (pd-1) antibodies and methods of use thereof | |
SG11201907754RA (en) | Anti-phf-tau antibodies and uses thereof | |
SG11201906341XA (en) | Improved serum albumin binders | |
SG11201806852PA (en) | Protein purification | |
SG11201804803WA (en) | Multi-specific antibody molecules having specificity for tnf-alpha, il-17a and il-17f | |
SG11201809374VA (en) | Cd40l-fc fusion polypeptides and methods of use thereof | |
SG11201908056QA (en) | Anti-par2 antibodies and uses thereof | |
SG11201804673WA (en) | Novel anti-claudin antibodies and methods of use | |
SG11201408780XA (en) | Optimization of antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof | |
SG11201908238SA (en) | Anti-c5 antibodies and uses thereof | |
SG11201403106SA (en) | Anti-phf-tau antibodies and their uses | |
SG11201908326YA (en) | Methods of treating neurodegenerative diseases | |
SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
SG11201900845YA (en) | Uses of il-13 antagonists for treating atopic dermatitis | |
SG11201407655TA (en) | Therapeutic uses of fibroblast growth factor 21 proteins | |
SG11201900744SA (en) | Fc engineered anti-tnfr superfamily member antibodies having enhanced agonistic activity and methods of using them | |
SG11201907927SA (en) | Binding molecules that specifically bind to tau | |
SG11201901468SA (en) | Antibodies with reduced binding to process impurities | |
SG11201910195WA (en) | Methods for trapping and barcoding discrete biological units in hydrogel |